Katya Shteyn net worth
Quick answer
Katya Shteyn's estimated net worth is $450.0M (range $315.0M – $675.0M) as of 2026. Katya Shteyn is Founder at BioRender. BioRender valuation.
Katya Shteyn is Founder at BioRender (YC W18). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Bachelor of Science (B.Sc.) in Computer Science from the University of Toronto
- Region: Canada
- Industries: B2B
- Team size: 205
- Website: https://www.biorender.com
Who is Katya Shteyn?
Katya Shteyn is the Co-founder and CTO of BioRender, a software platform that simplifies scientific research communication. She is an alumna of the Y Combinator W18 batch.
Highlights:
- Graduated from the University of Toronto with a B.Sc. in Computer Science
- Co-founded BioRender in 2017
- Participated in the Y Combinator W18 batch
About BioRender
You can think of BioRender as the ‘Figma/Canva for scientists’, with a suite of web-based graphics communication products to empower scientists to create beautiful scientific visuals and presentations with ease.
BioRender is the world’s first tool to help scientists create and share beautiful, professional scientific figures. Our mission is to accelerate the world’s ability to learn, discover and communicate...
FAQ: Katya Shteyn net worth and BioRender valuation
What is Katya Shteyn's net worth?
Katya Shteyn's estimated net worth is $450.0M (range $315.0M – $675.0M) as of 2026. Katya Shteyn is Founder at BioRender. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is BioRender valuation?
BioRender's estimated valuation on Entrepreneurial Check is $900.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Katya Shteyn's role?
Katya Shteyn is Founder at BioRender, a Y Combinator-backed startup (batch W18).